ERM promotes Th9 cell differentiation in the pathogenesis of ulcerative colitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051896

Enrollment

Unknown

Registered

2021-10-09

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

inflammatory bowel disease group:Peripheral blood was drawn, colon tissue was taken

healthy control group:Peripheral blood was drawn, colon tissue was taken

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with active ulcerative colitis.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Inflammatory factor expression levels;	—

Countries

China

Contacts

Public ContactShi Yan

Shanghai Sixth People's Hospital

sysh2014@126.com+86 13511691896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026